cetilistat   Click here for help

GtoPdb Ligand ID: 11433

Synonyms: ATL-962 | ATL962 | Oblean®
Approved drug
cetilistat is an approved drug (Japan (213))
Compound class: Synthetic organic
Comment: Cetilistat (ATL-962) is an orally active anti-obesity drug, that was designed to inhibit gastrointestinal and pancreatic lipases [1-2]. Its mechanism of action is similar to that of orlistat.
SARS-CoV-2: in a large scale screen of approved drugs, cetilistat exhibited potent in vitro anti-SARS-CoV-2 activity (EC50 1.13 μM in a plaque reduction assay) and dose-dependently reduced viral load [4].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 0
Rotatable bonds 16
Topological polar surface area 52.33
Molecular weight 401.29
XLogP 10.74
No. Lipinski's rules broken 2
Click here for help
Canonical SMILES CCCCCCCCCCCCCCCCOc1nc2ccc(cc2c(=O)o1)C
Isomeric SMILES CCCCCCCCCCCCCCCCOc1nc2ccc(cc2c(=O)o1)C
InChI InChI=1S/C25H39NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-28-25-26-23-18-17-21(2)20-22(23)24(27)29-25/h17-18,20H,3-16,19H2,1-2H3
No information available.
Summary of Clinical Use Click here for help
Cetilistat was approved for clinical use in Japan in 2013. It is not approved in the US or EU. It is indicated for the treatment of obesity and related disorders, including type 2 diabetes